Explore the vast range of titles available.

The cancer genome is characterized by extensive variability, in the form of Single Nucleotide Polymorphisms (SNPs) or structural variations such as Copy Number Alterations (CNAs) across wider genomic areas. At the molecular level, most SNPs and/or CNAs reside in non-coding sequences, ultimately affecting the regulation of oncogenes and/or tumor-suppressors in a cancer-specific manner. Notably, inherited non-coding variants can predispose for cancer decades prior to disease onset. Furthermore, accumulation of additional non-coding driver mutations during progression of the disease, gives rise to genomic instability, acting as the driving force of neoplastic development and malignant evolution. Therefore, detection and characterization of such mutations can improve risk assessment for healthy carriers and expand the diagnostic and therapeutic toolbox for the patient. This review focuses on functional variants that reside in transcribed or not transcribed non-coding regions of the cancer genome and presents a collection of appropriate state-of-the-art methodologies to study them.

Active‐targeting nanomedicine formulations have an intricate in vivo behavior. Nanomedicines developed to target endothelial αvβ3‐integrin are recently demonstrated to display extensive uptake by circulating phagocytes. These phagocytes show inherent tumor‐homing capacities and therefore are capable of actively delivering the endocytosed nanomaterial in lesions. Here, the targeting kinetics and mechanisms of cyclic arginine–glycine–aspartate (cRGD)‐decorated lipid nanoparticles (NPs) toward activated vasculature in inflamed lesions during wound healing are studied. The cRGD‐NP targeting toward inflamed lesions is identified to be mechanistically similar to the NP accumulation in cancerous lesions. Through a complementary experimental approach, it is observed that circulating phagocytes engage cRGD‐NPs and are subsequently homed to the inflamed endothelium. The inflammation‐associated phagocytes remain static among endothelial cells upon targeting, resulting in the extensive presence of cRGD‐NP‐positive phagocytes in the angiogenic vessels. Hence, phagocytic immune cells contribute to cRGD‐NP targeting toward angiogenesis. This mechanistic study underlines the need for detailed investigations of NP in vivo behavior. This is critically important for the realization of NPs potential as advanced (immunological) therapeutic agents. Decoration of lipid nanoparticles (NPs) with cyclic arginine–glycine–aspartate (cRGD) peptides results in extensive targeting of these NPs to neutrophils and monocytes in vivo. This enables the hitchhiking of cRGD‐NPs with myeloid immune cells toward inflammatory lesions. The discovery of such a targeting mechanism may open up possibilities for therapeutic or diagnostic use of cRGD‐NPs targeting pro‐inflammatory myeloid cells.

In article number 2100370, Alexandros Marios Sofias, Sjoerd Hak, and co‐workers, report that cRGD‐decorated lipid nanoparticles target inflammatory lesions via hitchhiking with phagocytes. Through a complementary approach including state‐of‐the‐art intravital microscopy, it is identified that neutrophils and monocytes take up cRGD‐decorated liposomes and nanoemulsions in circulation and subsequently home to the inflammatory lesion. Cover art: flowers (red) resemble phagocytes loaded with cRGD‐decorated lipid nanoparticles in the inflammatory lesion, grass (green) resembles the inflammatory lesion, foot‐path (yellow) resembles a blood vessel proximal to the inflamed tissue. Top‐right: distant view of the Norwegian University of Science and Technology (NTNU) campus.

The seismic hazard and risk analysis for the onshore Groningen gas field requires information about local soil properties, in particular shear-wave velocity (VS). A fieldwork campaign was conducted at 18 surface accelerograph stations of the monitoring network. The subsurface in the region consists of unconsolidated sediments and is heterogeneous in composition and properties. A range of different methods was applied to acquire in situ VS values to a target depth of at least 30 m. The techniques include seismic cone penetration tests (SCPT) with varying source offsets, multichannel analysis of surface waves (MASW) on Rayleigh waves with different processing approaches, microtremor array, cross-hole tomography and suspension P-S logging. The offset SCPT, cross-hole tomography and common midpoint cross-correlation (CMPcc) processing of MASW data all revealed lateral variations on length scales of several to tens of metres in this geological setting. SCPTs resulted in very detailed VS profiles with depth, but represent point measurements in a heterogeneous environment. The MASW results represent VS information on a larger spatial scale and smooth some of the heterogeneity encountered at the sites. The combination of MASW and SCPT proved to be a powerful and cost-effective approach in determining representative VS profiles at the accelerograph station sites. The measured VS profiles correspond well with the modelled profiles and they significantly enhance the ground motion model derivation. The similarity between the theoretical transfer function from the VS profile and the observed amplification from vertical array stations is also excellent.